Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4291217
Max Phase: Preclinical
Molecular Formula: C53H76N12O13S
Molecular Weight: 1121.33
Molecule Type: Small molecule
Associated Items:
ID: ALA4291217
Max Phase: Preclinical
Molecular Formula: C53H76N12O13S
Molecular Weight: 1121.33
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(C)[C@H](NC(=O)[C@@H](N)CS)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCCCNC(=O)c1ccc(CNC(=O)c2cc(=O)[nH]c3ccccc23)cc1)C(=O)N[C@H](C(=O)N[C@@H](C)C(N)=O)[C@@H](C)O)C(C)C)[C@@H](C)O
Standard InChI: InChI=1S/C53H76N12O13S/c1-26(2)40(62-49(74)38-16-12-22-65(38)53(78)43(30(7)67)64-51(76)41(27(3)4)61-47(72)35(54)25-79)50(75)60-37(48(73)63-42(29(6)66)52(77)58-28(5)44(55)69)15-10-11-21-56-45(70)32-19-17-31(18-20-32)24-57-46(71)34-23-39(68)59-36-14-9-8-13-33(34)36/h8-9,13-14,17-20,23,26-30,35,37-38,40-43,66-67,79H,10-12,15-16,21-22,24-25,54H2,1-7H3,(H2,55,69)(H,56,70)(H,57,71)(H,58,77)(H,59,68)(H,60,75)(H,61,72)(H,62,74)(H,63,73)(H,64,76)/t28-,29+,30+,35-,37-,38-,40-,41-,42-,43-/m0/s1
Standard InChI Key: MWTILWLYKQHUQA-LEGKKJBRSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1121.33 | Molecular Weight (Monoisotopic): 1120.5376 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Zhang H, Tomašič T, Shi J, Weiss M, Ruijtenbeek R, Anderluh M, Pieters RJ.. (2018) Inhibition of O-GlcNAc transferase (OGT) by peptidic hybrids., 9 (5): [PMID:30108977] [10.1039/C8MD00115D] |
Source(1):